Microbiology
Main Filters
Microbiology
| ADVANDX, INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| KT601 | 0 | - | ||
| MPS Pharma & Medical, Inc. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 17788HP3M | 0 | - | ||
| 17789HP | 0 | - | ||
| 17789HP3M | 0 | - | ||
| 17789HP3M-10PK | 0 | - | ||
| 17789HP3MLL-10PK | 0 | - | ||
| 2 PHARM-6 | 0 | - | ||
| G82711-M | 0 | - | ||
| G82713-M | 0 | - | ||
| G82721-M | 0 | - | ||
| G82721-MF | 0 | - | ||
| G827331-M | 0 | - | ||
| G82762-M | 0 | - | ||
| G82763-M | 0 | - | ||
| Opgen, Inc. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| CP3230 | 0 | - | ||
| CP3233 | 0 | - | ||
| CP3402 | 0 | - | ||
| CP3445 | 0 | - | ||
| POINTE SCIENTIFIC, INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| T8002-96 | 0 | - | ||
| T8003-96 | 0 | - | ||
| T8004-96 | 0 | - | ||
| T8005-96 | 0 | - | ||
| T8006-96 | 0 | - | ||
| T8007-96 | 0 | - | ||
| T81001-96 | 0 | - | ||
| SCIMEDX CORPORATION | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 104-100/10 | 0 | - | ||
| 201-302/150 | 0 | - | ||
| 201-302/500 | 0 | - | ||
| 201-302/500B | 0 | - | ||
| 201-610 | 0 | - | ||
| 400-110 | 0 | - | ||
| 400-120 | 0 | - | ||
| 400-150/100 | 0 | - | ||
| 7000 | 0 | - | ||
| 7000C | 0 | - | ||
| 700L | 0 | - | ||
| 700SC | 0 | - | ||
| 7023 | 0 | - | ||
| 7101 | 0 | - | ||
| 7105 | 0 | - | ||
| 7160 | 0 | - | ||
| 7182 | 0 | - | ||
| 7184 | 0 | - | ||
| CLEG | 0 | - | ||
| CLEGMIC | 0 | - | ||
| EG-96 | 0 | - | ||
| EH-96 | 0 | - | ||
| EH-96C | 0 | - | ||
| FI-96 | 0 | - | ||
| I-CMV01G | 0 | - | ||
13,132 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
Acuitas
Opgen, Inc.
Approximately 700 µl Master Mix in 1.5 ml screwcap tube with blue cap; component of KT03U01-2 Acuitas AMR Gene Panel Reagent Kit.
0
-
Acuitas
Opgen, Inc.
Assay Control is used to monitor extraction efficiency and PCR inhibition in the Acuitas AMR Gene Panel assay. A 2 mL screwcap tube containing approximately 90,000 CFU of Bacillus subtilis (ATCC 31028) dried down from a solution.
0
-
Acuitas
Opgen, Inc.
PCR Plate Seal Package component of KT03U01-1 Acuitas AMR Gene Panel PCR Assay Plate Kit consisting of two (2) PCR Plate Seals pouched in a labeled clear plastic bag.
0
-
Acuitas
Opgen, Inc.
Sealed, 96-well plate in Mylar Pouch. Each sealed and pouched Acuitas AMR Gene Panel PCR Plate contains four (4) panels of twenty-four (24) dried down, multiplexed PCR assays for use with the Acuitas AMR Gene Panel.
0
-
Pointe Scientific, Inc. HSV-1 & 2 IgG
POINTE SCIENTIFIC, INC.
Pointe Scientific, Inc. HSV-1 & 2 IgG Reagent is for the qualitative, and semi-quantitative detection of human IgG antibodies to type 1 and type 2 herpes simplex virus (HSV) in human serum by enzyme immunoassay. To aid in the evaluation of the patient's immunological history with HSV, including women of childbearing age. These reagents have not received FDA clearance for use in testing blood or plasma donors. 96 tests.
0
-
Pointe Scientific, Inc. CMV IgM
POINTE SCIENTIFIC, INC.
Pointe Scientific, Inc. CMV IgM Reagent is for the qualitative detection of human IgM antibodies to cytomegalovirus (CMV) in human serum by enzyme immunoassay, to aid in the diagnosis of CMV infection. A positive result is presumptive for the detection of anti-CMV IgM antibodies and presumptive for the diagnosis of acute or recent CMV infection. These reagents have not received FDA clearance for use in testing blood or plasma donors. 96 tests.
0
-
Pointe Scientific, Inc. CMV IgG
POINTE SCIENTIFIC, INC.
Pointe Scientific, Inc. CMV IgG Reagent is for the detection of human IgG antibodies to cytomegalovirus virus in human serum by enzyme immunoassay, as an aid in the determination of acute or reactivated infection with CMV. When used as a qualitative test, CMV IgG EIA aids in the assessment of the patient's immunological response to CMV. These reagents have not received FDA clearance for use in testing blood or plasma donors. 96 tests
0
-
Pointe Scientific, Inc. Rubella IgM
POINTE SCIENTIFIC, INC.
Pointe Scientific, Inc. Rubella IgM is for the qualitative detection of human IgM antibodies to rubella virus in human serum by enzyme immunoassay, to aid in the diagnosis of rubella infection. A positive result is presumptive for the detection of anti-rubella IgM antibodies and presumptive for the diagnosis of acute or recent rubella infection. 96 tests
0
-
Pointe Scientific, Inc. Rubella IgG
POINTE SCIENTIFIC, INC.
Pointe Scientific, Inc. Rubella IgG is for the qualitative, semi-quantitative and quantitative detection of human IgG antibodies to rubella virus in human serum by enzyme immunoassay, to aid in the assessment of the patient's immunological response to rubella, and as a qualitative screening test to determine the immune status of individuals, including women of childbearing age. These reagents have not received FDA clearance for use in testing blood or plasma donors. 96 tests
0
-
Pointe Scientific, Inc. Toxoplasma IgM
POINTE SCIENTIFIC, INC.
Pointe Scientific, Inc. Toxoplasma IgM Reagent is for the qualitative and quantitative detection of human IgM antibodies to Toxoplasma in human serum by enzyme immunoassay, to aid in the diagnosis of Toxoplasma infection. A positive result is presumptive for the detection of anti-Toxoplasma gondii antibodies and presumptive for the diagnosis of acute, recent, or reactivated Toxoplasma gondii infection. Patient testing with anti-Toxoplasma gondii IgM antibody assay, must be accompanied by an anti-Toxoplasma gondii IgG antibody assay. The assay’s performance characteristics have not been established for neonatal toxoplasmosis diagnosis. This assay has not been cleared / approved by the FDA for blood / plasma donor screening. 96 tests.
0
-
Pointe Scientific, Inc. Toxoplasma IgG
POINTE SCIENTIFIC, INC.
Pointe Scientific, Inc. Toxoplasma IgG Reagent is for the qualitative, semi-quantitative or quantitative detection of human IgG antibodies to Toxoplasma gondii in human serum by enzyme immunoassay, as an aid in the determination of infection with Toxoplasma. When used as a qualitative test, Toxoplasma IgG EIA aids in the assessment of the patient's immunological response to toxoplasma. These reagents have not received FDA clearance for use in testing blood or plasma donors. 96 tests
